On 7 AUG OncoGenex Pharmaceuticals, Inc. (NASDAQ:OGXI) announced second quarter 2014 financial results. Revenue for the three and six months ended June 30, 2014 was $4.9 million and $16.7 million, respectively.  This compares with $6.3 million and $11.4 million, respectively, in the same periods in 2013. Revenue earned in the second quarter of 2014 consists of reimbursable clinical trial, manufacturing and preclinical costs incurred by OncoGenex under the collaboration agreement with Teva. OncoGenex Pharmaceuticals, Inc. (NASDAQ:OGXI) belongs to Healthcare sector. Its net profit margin is -92.30% and weekly performance is -1.22%. On last trading day company shares ended up $3.25. OncoGenex Pharmaceuticals, Inc. (NASDAQ:OGXI) distance from 50-day simple moving average (SMA50) is -1.27%.

On 11 AUG Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) last announced its earnings results on Monday. The company reported $2.61 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.67 by $0.94. The company had revenue of $42.10 million for the quarter, compared to the consensus estimate of $40.83 million. The company’s revenue for the quarter was up 2531.3% on a year-over-year basis. Analysts expect that Enanta Pharmaceuticals will post $1.35 EPS for the current fiscal year. Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) shares advanced 1.04% in last trading session and ended the day at $39.95. ENTA return on assets is 32.50%. Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) quarterly performance is 1.50%.

On 21 AUG The Cheesecake Factory Incorporated (NASDAQ:CAKE) Insider Max S. Byfuglin sold 10,661 shares of The Cheesecake Factory stock on the open market in a transaction that occurred on Thursday. The stock was sold at an average price of $44.55, for a total value of $474,947.55. Following the transaction, the insider now directly owns 21,100 shares in the company, valued at approximately $940,005.  On 25 August, The Cheesecake Factory Incorporated (NASDAQ:CAKE) shares advanced 1.64% and was closed at $45.21. CAKE EPS growth in last 5 year was 20.70%. The Cheesecake Factory Incorporated (NASDAQ:CAKE) year to date (YTD) performance is -5.40%.

On 7 AUG Randgold Resources Limited (NASDAQ:GOLD) last posted its quarterly earnings results on Thursday. The company reported $0.56 earnings per share for the quarter, missing the analysts’ consensus estimate of $0.79 by $0.23. The company had revenue of $294.90 million for the quarter, compared to the consensus estimate of $288.74 million. During the same quarter last year, the company posted $0.50 earnings per share. On average, analysts predict that Randgold Resources Ltd. will post $3.31 earnings per share for the current fiscal year. Randgold Resources Limited (NASDAQ:GOLD) ended the last trading day at $80.69. Company weekly volatility is calculated as 1.26%and price to cash ratio as 255.65. Randgold Resources Limited (NASDAQ:GOLD) showed a weekly performance of -4.61%.

 

On 7 AUG OvaScience, Inc. (NASDAQ:OVAS) reported second quarter 2014 financial results and highlighted recent accomplishments. Net loss for the three months ended June 30, 2014 was $9.9 million, or ($0.42) per share, as compared to net loss of $6.0 million, or ($0.36) per share, for the three months ended June 30, 2013. The increase for the quarter is primarily attributable to planned higher personnel costs, including stock-based compensation expense, additional research and development outside services and lab operations, and costs associated with the international launch of the AUGMENT treatment. OvaScience, Inc. (NASDAQ:OVAS) shares advanced 3.79% in last trading session and ended the day on $12.32. OVAS return on assets is -51.40%. OvaScience, Inc. (NASDAQ:OVAS) quarterly performance is 62.53%.